| |
| |
|
| Insider
Information: |
Myszkowski Kenneth Allen |
| Relationship: |
Chief Financial Officer |
| City: |
Pasadena |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
400,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,193,770 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
400,600 |
|
|
| Total
Value |
$9,193,770 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -108.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arrowhead Pharmaceuticals Inc |
ARWR |
Chief Financial Officer |
2024-03-06 |
400,600 |
2010-08-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-05-31 |
4 |
OE |
$2.01 |
$25,326 |
D/D |
12,600 |
323,415 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-05-31 |
4 |
AS |
$11.00 |
$138,600 |
D/D |
(12,600) |
310,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-06-19 |
4 |
OE |
$2.01 |
$40,200 |
D/D |
20,000 |
330,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-06-19 |
4 |
AS |
$14.01 |
$280,200 |
D/D |
(20,000) |
310,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-09-06 |
4 |
OE |
$2.62 |
$160,500 |
D/D |
45,000 |
355,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-09-06 |
4 |
AS |
$18.00 |
$870,200 |
D/D |
(45,000) |
310,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
395,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-01-02 |
4 |
AS |
$11.98 |
$99,829 |
D/D |
(8,333) |
387,482 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-01-17 |
4 |
AS |
$14.55 |
$1,191,281 |
D/D |
(81,875) |
305,607 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-02-19 |
4 |
OE |
$5.20 |
$41,600 |
D/D |
8,000 |
313,607 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-02-19 |
4 |
AS |
$18.00 |
$144,000 |
D/D |
(8,000) |
305,607 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-05-21 |
4 |
AS |
$22.00 |
$595,562 |
D/D |
(27,071) |
278,536 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-05-31 |
4 |
OE |
$4.60 |
$172,800 |
D/D |
35,000 |
313,536 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-11-01 |
4 |
AS |
$40.56 |
$1,547,378 |
D/D |
(37,884) |
313,536 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-11-01 |
4 |
OE |
$7.75 |
$293,601 |
D/D |
37,884 |
351,420 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-11-05 |
4 |
OE |
$5.19 |
$65,648 |
D/D |
12,649 |
326,185 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
411,185 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-01-06 |
4 |
AS |
$59.60 |
$1,202,201 |
D/D |
(20,000) |
391,185 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-01-21 |
4 |
OE |
$5.19 |
$173,092 |
D/D |
33,351 |
424,536 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-01-21 |
4 |
AS |
$47.07 |
$1,992,925 |
D/D |
(40,313) |
384,223 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-02-25 |
4 |
OE |
$5.19 |
$384,145 |
D/D |
43,445 |
427,668 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-10-20 |
4 |
AS |
$54.04 |
$1,576,131 |
D/D |
(29,166) |
427,668 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-10-20 |
4 |
OE |
$6.15 |
$179,371 |
D/D |
29,166 |
456,834 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-11-09 |
4 |
OE |
$14.54 |
$632,563 |
D/D |
43,505 |
471,173 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2020-11-09 |
4 |
AS |
$69.04 |
$3,018,071 |
D/D |
(43,505) |
427,668 |
0 |
% |
|
62 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
